Related Experiment Video
Updated: May 29, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Resistant hypertension: concepts and approach to management
Gary E Sander1, Thomas D Giles
1Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70005, USA.
Resistant hypertension (RH) affects many, but careful assessment can reveal white coat effects or adherence issues in up to 30% of cases. True RH requires targeted treatments addressing underlying mechanisms like aldosterone signaling and sympathetic activity.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Resistant hypertension (RH) is defined as blood pressure (BP) requiring four or more antihypertensive agents.
- RH is prevalent in elderly patients, potentially affecting 20% of the hypertensive population.
- Pseudoresistance due to improper BP measurement, non-adherence, or interfering medications must be excluded.
Purpose of the Study:
- To review the definition, prevalence, and diagnostic challenges of resistant hypertension.
- To explore the underlying pathophysiologic mechanisms driving true RH.
- To outline current and emerging therapeutic strategies for managing RH.
Main Methods:
- Literature review of studies on resistant hypertension diagnosis and management.
- Analysis of pathophysiologic mechanisms including aldosterone signaling, sympathetic overactivity, and fluid retention.
- Evaluation of pharmacologic and device-based therapeutic interventions.
Main Results:
- Approximately 30% of patients evaluated for RH exhibit white coat hypertension or pseudoresistance.
- Key mechanisms of true RH include aldosterone abnormalities, sodium retention, sympathetic nervous system overactivity, and obstructive sleep apnea.
- Standard treatment involves renin-angiotensin-aldosterone system inhibitors, calcium channel blockers, and diuretics, with aldosterone blockers as a fourth agent.
Conclusions:
- Accurate diagnosis of RH requires excluding pseudoresistance and white coat effects through careful monitoring.
- Targeted treatment based on specific patient profiles and underlying mechanisms is crucial for effective RH management.
- Novel device therapies targeting sympathetic denervation show promise for future RH treatment.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
